인쇄하기
취소

NHI coverage to expand to major cancer drugs.

Published: 2006-01-13 06:57:00
Updated: 2006-01-13 06:57:00
The NHI (national health insurance) reimbursement standards for anti-cancer drugs such as Iressa, Zeloda and Taxol inj. seem to be expanded.

The Cancer Disease Review Council of HIRA prepared detailed plans for the NHI coverage to cancer patients especially over chemotherapy, anti-vomiting and pain killer against major solid tumors.

The 514 anti-cancer drugs were finally determined for t...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.